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Abstract
Pancreatic cancer remains one of the most difﬁcult
neoplasms for early diagnosis and treatment. Recent
advances of imaging including 3D volume data setting in
multidetector-row CT (MDCT) and MRI are urging us
to focus on the imaging of normal and pathological
conditions of pancreatic parenchyme and peripancreatic
structures, which are frequently involved by pancreatic
cancers and are affecting the prognosis of patients with
pancreatic cancers. In this Feature Section, ﬁve main
topics of pancreatic imaging are addressed: pancreatic
arterial territories, imaging of the intra- and peripan-
creatic venous anatomy and its clinical signiﬁcance,
imaging of the peripancreatic lymphatic network and its
clinical signiﬁcance for staging of pancreatic cancer,
perfusion characteristics of pancreatic cancer to differ-
entiate chronic mass-forming pancreatitis, and develop-
ment of intraductal papillary mucinus neoplasms of the
pancreas (IPMNs) to adenocarcinoma and pancreatic
invasion. Recognition and understanding of the imaging
anatomy of the pancreas might lead to precise staging of
pancreatic cancer and to new approaches of less-invasive
treatment. Follow-up of patients with IPMNs of the
pancreas on imaging seems, at this time, to be the most
valuable strategy in the high-risk group selection.
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Pancreatic cancer remains one of the most difﬁcult neo-
plasms for early diagnosis and treatment. During the
past few decades, the incidence of pancreatic carcinomas
has increased all over the world, and these tumors have
become the 4th or 5th most common cause of death from
cancer. Only 10%–30% of patients with pancreatic car-
cinoma have resectable disease at diagnosis. Therefore,
long-term survival is extremely rare. Many researchers
have been making every effort to ﬁnd a way for early
diagnosis, accurate staging, and effective treatment of
pancreatic cancers. However, it was recently reported
that use of the brand-new molecular-targeted drug with
gemcitebine for systemic chemotherapy of patients with
advanced pancreatic cancers could extend median sur-
vival by only one month [1]. So, when considering the
strategy of diagnosis and treatment of pancreatic cancer,
the following questions arise: How and what do we know
about the anatomy of the pancreas? Do we miss some-
thing very basic?
The term pancreas is derived from Greek and means
literally ‘‘an organ colored like beef or meat.’’ The Chi-
nese character representing pancreas in Japanese means
‘‘an organ which consists of glands.’’ On the other hand,
the original Chinese character representing pancreas
means ‘‘an organ of remote region or unexplored terri-
tory’’ (Fig. 1). It is indeed true that the pancreas is still
an unexplored organ, compared to the liver whose arte-
rial, portal venous, hepatic venous, and segmental
anatomy had been well established many years ago [2].
Little attention has been paid to the arterial territory of
the pancreas, the anatomy of intra- and peripancreatic
veins, and the anatomy of peripancreatic lymphatic
networks.
In this Feature Section, ﬁve main topics of pancreatic
imaging are addressed: pancreatic arterial territories,
imaging of the intra- and peripancreatic venous anatomy
and its clinical signiﬁcance, imaging of the peripancreatic
lymphatic network and its clinical signiﬁcance for staging
of pancreatic cancer, perfusion characteristics of pan-
creatic cancer to differentiate chronic mass-forming
pancreatitis, and development of IPMNs (Intraductal
papillary mucinus neoplasms of the pancreas) to ade-
nocarcinoma and pancreatic invasion. The content is
outlined here with some supplements.
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Arterial territories or segmental anatomy
of the pancreas
It is not surprising that there had been no solid concept
of the arterial territories or segments of the pancreas [3],
because there was little clinical need for pancreatic seg-
mentectomy or segmental resection; also there had been
little clinical success of the less-invasive targeted therapy.
As shown in this Feature Section, follow-up by imaging
of patients with intraductal mucinous neoplasms (IP-
MNs) of the pancreas may be the most effective way to
find the early-stage pancreatic cancer. Pancreatic seg-
mentectomy has precisely been discussed for the IPMNs
[4, 5]. Clinical application of the less invasive targeted
therapy such as intra-arterial chemotherapy [6] or gene
therapy [7–9] is in the early stages. In the near future,
knowledge of the arterial territories or segmental anat-
omy of the pancreas will be appreciated for both surgery
and locally targeted less-invasive therapy. In this Feature
Section, Dr. Okahara and colleagues describe the ana-
tomical variations and arterial territories (segments) of
the pancreas using CT during selective arterial injection
of contrast medium.
Anatomy of the pancreatic veins
The assessment of tumor invasion to the portal-superior
mesenteric veins is crucial for surgical planning in
patients who are potentially resectable. The criteria for
evaluation of cancer extension to Portal-SMV were
proposed in several previous reports [10]. Observing the
pancreaticoduodenal veins is valuable for obtaining
additional information regarding curability, because they
have a close relationship with the extrapancreatic nerve
plexus and the root of the small bowel mesentery. The
anatomy of the peripancreatic veins of the pancreatic
head has been well established [11–13]. CT assessments
of the small pancreaticoduodenal veins in patients with
pancreatic carcinoma can help to reliably identify
vascular invasion earlier in the course of invasive carci-
noma. Understanding the normal CT anatomy of the
peripancreatic and intrapancreatic veins, not only in the
pancreatic head but also in the body and tail areas, is a
prerequisite for evaluating these veins in patients with
pancreatic disease.
Recently, multiplanar reformation (MPR) in dynamic
contrast-enhanced studies facilitated by multidetector-
row CT (MDCT) has allowed conﬁdent and accurate
three-dimensional assessment of small pancreatic veins.
Speciﬁcally, high-resolution MDCT images obtained
using the MPR technique, especially the thin-slice images
(1 or 2 mm in thickness) acquired by MDCT and MPR
using high iodine concentration contrast media, have
allowed the identiﬁcation of these small pancreatic veins.
In this Feature Section, Dr. Hongo and colleagues de-
scribe detailed anatomic variation of the venous drainage
of intrapancreatic veins by analysis of the venous phase
of multidetector-row CT (MDCT).
Extrapancreatic neural plexus and
peripancreatic lymphatic networks
The new UICC TNM classiﬁcation published in 2002
reﬂects the inﬂuencing prognostic factors of patients with
pancreatic cancer [14]. In clinical practice, there are very
few patients with stage I pancreatic cancer because there
is no screening method established (nor risk-group set-
ting) for pancreatic cancer at this point. Furthermore, it
is very important to know that even T1 pancreatic cancer
can infiltrate surrounding peripancreatic tissue including
regional lymph nodes [15]. Despite recent advances of
imaging including 3D volume data setting in multide-
tector-row CT (MDCT) and MRI, little attention has
been paid to imaging of normal and pathological con-
ditions of peripancreatic lymphatic networks, peripan-
creatic neural plexuses, and pancreatic veins, which are
frequently involved by pancreatic cancers and affect the
prognosis of patients with pancreatic cancers.
Retroperitoneal inﬁltration via extrapancreatic nerve
plexuses is one of the major causes of postoperative
recurrence. The second portion of the pancreatic head
nerve plexus is frequently involved and is contiguous to
the root of the small bowel mesentery. The normal ex-
trapancreatic nerve plexus can hardly be seen on CT, but
it is known that the inferior pancreaticoduodenal artery
(IPDA) and vein (IP) pass through the second portion of
the pancreatic head nerve plexus [16, 17]. Recently,
evaluation by CT is reported to be able to demonstrate
tumor invasion to the extrapancreatic nerve plexus
showing obliteration of the IP and/or the first jejunal
trunk (JT) [18].
Imaging ﬁndings of peripancreatic lymphatic invasion
by pancreatic cancer have not been described before,
though lymphatic networks exist around the pancreas
having close anatomical relationship with neural plexuses
and blood vessels. On pathologic examinations, there
may be two ways of peripancreatic lymphatic invasion by
Fig. 1. Pancreas as unexplored territory. Upper row: Japa-
nese Kanji (Chinese character) representing pancreas means
‘‘an organ consisting of glands.’’ Lower row: Chinese char-
acter representing pancreas means ‘‘ an organ of remote
region’’ or ‘‘ an organ of unexplored territory’’.
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lymphatics [19] and tumor extension along the lymphatic
channels (Fig. 2). In this Feature Section, Dr. Sai and
colleagues describe the CT features of normal peripan-
creatic lymphatic networks, and state that areas of in-
creased attenuation in the peripancreatic fat plane
corresponding with anatomical networks in the patients
with known pancreatic cancer may indicate cancer
invasion to lymphatics.
Differentiation of pancreatic cancer
from pancreatic ﬁbrosis by perfusion
characteristics on CT and MRI
In some clinical cases, difﬁculties can arise in the differ-
entiation of autoimmune pancreatitis (AIP) and mass-
forming chronic pancreatitis from pancreatic cancer
[20, 21]. Late enhancement of pancreatic carcinomas has
been observed on CT by a few investigators [22, 23]. On
delayed phased MRI, significant differences between
enhancement of cancer and benign fibrosis have been
reported [24]. Rich fibrotic stroma in pancreatic adeno-
carcinoma would play a major role in these perfusion
characteristics along with architectures of so-called tu-
mor vessels [25] and vascularity of the cancer. In this
Feature Section, Dr. Hata and colleagues describe the
time-attenuation curve (TAC) pattern of pancreatic
cancer on triple-phase postcontrast CT with correlation
to histopathologic features including amount of fibrotic
stroma and vascularity. Dr. Yamada and colleagues de-
scribe TAC patterns of normal pancreatic parenchyma,
chronic pancreatitis, and pancreatic cancer. Chronic
pancreatitis and pancreatic adenocarcinoma could be
differentiated according to TACs of the second and third
phases obtained during triple-phase CT with diagnostic
accuracy of around 90%.
IPMNs as a clue for detecting
early-stage pancreatic cancer
The risk of developing pancreatic cancer for patients
with hereditary pancreatitis (HP) is extremely high [26].
This poses opportunities for secondary screening in those
patients. Otherwise there has been no effective screening
method for detecting early-stage pancreatic cancer,
though a lot of clinical efforts have been made. Periodic
checkups by imaging and/or EUS (endoscopic ultra-
sound) for patients with main pancreatic duct dilatation
or cystic lesions are considered to be an effective method
for the early detection of pancreatic cancer [27]. The
possibility of clinical utility of genomic abnormalities
including tumor suppressor genes such as Ki-67, p53,
and DPC4 remains unclear. Stool K-ras analysis has
been reported as a potential screening method for the
early detection of pancreatic adenocarcinoma and pre-
cursor lesions such as pancreatic ductal mucinous cell
hyperplasia [28]. Identifying the responsible gene
abnormalities for early pancreatic cancer using array-
based comparative genomic hybridization is just in the
early stages.
Intraductal papillary mucinous neoplasm (IPMN) is a
relatively new entity and has been increasingly recog-
nized recently as belonging to a well-characterized group
of intraductal mucin-producing neoplasms of the pan-
creas with malignant potential [29]. Thin-section
dynamic CT has been shown to be a useful modality for
follow-up of IPMNs, especially those that have pro-
gressed into invasive carcinomas [30, 31]. When a solid
mass in the pancreatic parenchyma surrounding the
dilated pancreatic ducts appears on follow-up CT,
progression to an invasive carcinoma should be consid-
ered and surgical resection is recommended. In this
Feature Section, Dr. Yamada and colleagues describe the
Fig. 2. Lymphatic spread of
pancreatic cancer. Axial images
of postcontrast CT showed
some linear areas of increased
attenuation (arrows, b) in the
retroperitoneal fat planes which
are contiguous to the cancer of
pancreatic tail (CA, a, b).
Resected specimen revealed
cancer invasion along the
lymphatic channels (arrows, c)
which are contiguous to the
cancer of the tail (CA, c). The
foci of cancer cells in the
peripancreatic fat are associated
with fibrous stroma similar to the
primary cancer (CA, c).
132 H. Mori: New insight of pancreatic imagingimaging features of the invasive carcinoma originating
from intraductal papillary mucinous neoplasms of the
pancreas.
Conclusion
Recognition and understanding of the imaging anatomy
of the pancreas, including pancreatic veins, lymphatic
pathways, and extrapancreatic neural plexuses, might
lead to the accurate staging of pancreatic cancer.
Knowledge of arterial territories or segmental anatomy
of the pancreas might be useful for locally targeted
treatments for pancreatic cancer. Understanding perfu-
sion characteristic of pancreatic cancer, which is deter-
mined by the vascularity and presence of ﬁbrotic stroma,
can differentiate cancer from benign pancreatic ﬁbrosis.
Careful follow-up of IPMNs leads to detection of early-
stage pancreatic cancers.
I sincerely hope that the knowledge communicated in
this Feature Section will be shared by many clinical
researchers and will underscore the next step in pancre-
atic imaging and treatment.
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